HYFTOR
sirolimus
- Strength
- 2 mg/g
- Form
- Gel
- Class
- Kinase Inhibitor; mTOR Inhibitor Immuno…
Nobelpharma America, LLC
Sirolimus
Listed by Aadi Bioscience, Inc.
| Dosage form | Injection, Powder, Lyophilized, For Suspension |
|---|---|
| Route | Intravenous |
| Drug class | Kinase Inhibitor; mTOR Inhibitor Immunosuppressant |
| Approval route | NDA — original brand approval |
| NDC code | 80803-153 |
| FDA application | NDA213312 |
| RxNorm concept | 2586863 |
| Package sizes listed | 1 |
| Marketed since | December 2021 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
sirolimus
Nobelpharma America, LLC
Dr. Reddy's Laboratories Limited
REMEDYREPACK INC.
REMEDYREPACK INC.
Rising Pharma Holdings, Inc.
Mylan Pharmaceuticals Inc.
Zydus Lifesciences Limited
Ascend Laboratories, LLC
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.